Aortic and Mitral Valve Endocarditis—Simply Left-Sided Endocarditis or Different Entities Requiring Individual Consideration?—Insights from the CAMPAIGN Database
Authors:
- Carolyn WeberCWCarolyn Weber
- Mateo Marin-CuartasMMMateo Marin-Cuartas
- Sems-Malte TugtekinSTSems-Malte Tugtekin
- Mahmoud DiabMDMahmoud Diab
- Shekhar SahaSSShekhar Saha
- Payam AkhyariPayam Akhyari
- Ahmed ElderiaAEAhmed Elderia
- Florian MuenchFMFlorian Muench
- Asen PetrovAPAsen Petrov
- Hug AubinHAHug Aubin
- Martin MisfeldMMMartin Misfeld
- Artur LichtenbergALArtur Lichtenberg
Open Access
- 30 September 2024
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (19) , 5841
Abstract
Background: Aortic valve infective endocarditis (AV-IE) and mitral valve infective endocarditis (MV-IE) are often grouped together as one entity: left-sided endocarditis. However, there are significant differences between the valves in terms of anatomy, physiology, pressure, and calcification tendency. This study aimed to compare AV-IE and MV-IE in terms of patient characteristics, pathogen profiles, postoperative outcomes, and predictors of mortality. Methods: We retrospectively analyzed data from 3899 patients operated on for isolated AV-IE or MV-IE in six German cardiac surgery centers between 1994 and 2018. Univariable and multivariable analyses were performed to analyze the risk factors for 30 day and 1 year mortality. A Log-rank test was used to test for differences in long-term mortality. Results: Patients with MV-IE were more likely to be female (41.1% vs. 20.3%.; p < 0.001). Vegetation was detected more frequently in the MV-IE group (66.6% vs. 57.1%; p < 0.001). Accordingly, the rates of cerebral embolic events (25.4% vs. 17.7%; p < 0.001) and stroke (28.2% vs. 19.3%; p < 0.001) were higher in the MV-IE group. Staphylococci had a higher prevalence in the MV-IE group (50.2% vs. 36.4%; p < 0.001). Patients with MV-IE had comparable 30 day mortality (16.7% vs. 14.6%; p = 0.095) but significantly higher 1 year mortality (35.3% vs. 29.0%; p < 0.001) than those with AV-IE. Kaplan–Meier survival analysis showed significantly lower long-term survival in patients with MV-IE (log-rank p < 0.001). Conclusions: Due to the relevant differences between MV-IE and AV-IE, it might be useful to provide individualized, valve-specific guideline recommendations rather than general recommendations for left-sided IE.Keywords
This publication has 30 references indexed in Scilit:
- Endocarditis-related stroke is not a contraindication for early cardiac surgery: an investigation among 440 patients with left-sided endocarditisEuropean Journal of Cardio-Thoracic Surgery, 2020
- Bacterial biofilms in infective endocarditis: an in vitro model to investigate emerging technologies of antimicrobial cardiovascular device coatingsClinical Research in Cardiology, 2020
- Severity of Presentation, Not Sex, Increases Risk of Surgery for Infective EndocarditisThe Annals of Thoracic Surgery, 2019
- S. aureus endocarditis: Clinical aspects and experimental approachesInternational Journal of Medical Microbiology, 2018
- The relationship between causative microorganisms and cardiac lesions caused by infective endocarditis: New perspectives from the contemporary cohort of patientsJournal of Cardiology, 2018
- Residual patient, anatomic, and surgical obstacles in treating active left-sided infective endocarditisThe Journal of Thoracic and Cardiovascular Surgery, 2014
- Clinical Presentation, Etiology, and Outcome of Infective Endocarditis in the 21st CenturyArchives of internal medicine (1960), 2009
- Gender Differences in Mortality After Mitral Valve Operation: Evidence for Higher Mortality in Perimenopausal WomenThe Annals of Thoracic Surgery, 2008
- The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: An analysis from the ICE Prospective Cohort Study (ICE-PCS)American Heart Journal, 2007
- Proposed Modifications to the Duke Criteria for the Diagnosis of Infective EndocarditisClinical Infectious Diseases, 2000